Size of drug companies needs larger through M&A

Published: 2005-10-25 06:58:00

Updated: 2005-10-25 06:58:00

An industry analyst alleged that in one way or the other possibly through M&A the pharmaceutical company size should make larger than now to compete with the foreign multinational drug corporations and to upgrade its competitiveness on the global markets by putting more efforts to the promotion o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK